Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Ecancermedicalscience|March 4, 2022
Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the doorMauro Daniel Spina Donadio, Dirce Maria Carraro, Giovana Tardin Torrezan, et al.Journal of Personalized Medicine|July 25, 2025
Neuroendocrine Neoplasms in Pregnancy: A Narrative Review of Clinical Challenges and Therapeutic Limitations in the Absence of Established Safe TreatmentsMauro Daniel Spina Donadio, Maria Cecília Mathias-Machado, Danielly Scaranello Nunes Santana, et al.Therapeutic Advances in Medical Oncology|July 29, 2024
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Ângelo Borsarelli Carvalho de Brito, et al.Journal of Gastrointestinal Oncology|August 29, 2018
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinomaVictor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, et al.Journal of Gastrointestinal Oncology|December 4, 2018
Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOXVictor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, et al.Journal of Surgical Oncology|November 28, 2018
Clinico-pathological features and survival of patients with malignant exocrine pancreatic neoplasms: The AC Camargo Cancer Center experienceVictor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, et al.Endocrine-Related Cancer|March 22, 2023
Germline pathogenic variants in patients with early-onset neuroendocrine neoplasmsRachel Pimenta Riechelmann, Mauro Daniel Spina Donadio, Victor Hugo Fonseca de Jesus, et al.Pageof 1